Hong Kong Pharma (HKPD) | Stock Overview & Key Data
Hong Kong Pharma Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $3.79 on January 13, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Hong Kong Pharma
HKPD
|
14.64M Micro-cap | -10.20% | -16.98% | -29.03% | -41.33% | -45.68% | -73.03% | -85.09% | -85.09% | -85.09% | -85.09% | -85.09% |
|
Walgreens Boots
WBA
|
10.35B Large-cap | -1.72% | 3.01% | 7.06% | 11.86% | 11.86% | 29.51% | -66.03% | -67.53% | -86.30% | -57.67% | -73.45% |
|
High Tide
HITI
|
210.95M Micro-cap | -3.02% | -6.64% | -9.64% | -17.58% | -19.64% | 1.32% | 81.89% | -69.20% | -26.67% | -26.67% | -26.67% |
|
PetMed Express
PETS
|
47.72M Micro-cap | 7.65% | -17.94% | -25.00% | -36.24% | -44.55% | -48.18% | -86.86% | -94.29% | -89.86% | -84.44% | -86.31% |
|
Wellgistics Health
WGRX
|
17.27M Micro-cap | -6.97% | -10.95% | -54.94% | -87.10% | -82.76% | -94.77% | -98.17% | -98.17% | -98.17% | -98.17% | -98.17% |
|
Scienture Holdings
SCNX
|
16.98M Micro-cap | 2.86% | -10.00% | -20.00% | -34.55% | -30.77% | -64.49% | -92.05% | -99.44% | -97.30% | -98.31% | -98.31% |
Ownership & Short Interest
Calculate Your Hong Kong Pharma Investment Returns
Long-Term Investment Performance Analysis
Hong Kong Pharma stock price in Jan 2025 was $2.75, A $1,000.00 lump sum investment in Hong Kong Pharma made 1 years ago would be worth approximately $160.00 today, representing a negative return of -84.00%. This translates to an annualized return (CAGR) of -72.53%.
1 Year 5 Months Investment Scenario (Jan 2025 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is HKPD's 52-week high and low?
- In the last 52 weeks, Hong Kong Pharma reached a high of $2.58 (on August 26, 2025) and a low of $0.32 (on June 10, 2026).
- What is the market cap and P/E ratio for HKPD?
- Curious about Hong Kong Pharma's size and valuation? Its market capitalization stands at 14.64M. When it comes to valuation, the P/E ratio (trailing twelve months) is 6.26, and the forward P/E (looking ahead) is N/A.
- Does HKPD pay dividends? If so, what's the yield?
- As for dividends, Hong Kong Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Hong Kong Pharma's main competitors or similar companies to consider before investing?
When looking at Hong Kong Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Walgreens Boots
WBA10.35B Healthcare Pharmaceutical Retailers 29.51% -66.03% High Tide
HITI210.95M Healthcare Pharmaceutical Retailers 1.32% 81.89% PetMed Express
PETS47.72M Healthcare Pharmaceutical Retailers -48.18% -86.86% Wellgistics Health
WGRX17.27M Healthcare Pharmaceutical Retailers -94.77% -98.17% Scienture Holdings
SCNX16.98M Healthcare Pharmaceutical Retailers -64.49% -92.05% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hong Kong Pharma Digital Technology Co. Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Hong Kong Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -13.38%, the Debt to Equity ratio from the most recent quarter is 44.19, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for HKPD?
- Looking at Hong Kong Pharma's growth, its revenue over the trailing twelve months (TTM) was $16M. Compared to the same quarter last year (YoY), quarterly revenue grew by -35.70%, and quarterly earnings saw a YoY growth of -81.40%.
- How much of HKPD stock is held by insiders and institutions?
- Wondering who owns Hong Kong Pharma stock? Company insiders (like executives and directors) hold about 62.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.36%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.